Skip to main content
OpenTrials

Clinical trial condition

Panuveitis

Explore clinical trials studying Panuveitis. Study availability and eligibility vary by location and protocol.

22 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Panuveitis trial results

Completed

Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis

NCT00615693

Conditions
Eye Diseases, Macular Degeneration, Macular Edema, +7 more
Locations
  • University of Southern California Doheny Eye Institute Los Angeles, California, United States
  • University of California San Francisco, California, United States
  • Colorado Retina Associates Denver, Colorado, United States
  • University of Miami Miller School of Medicine; Anne Bates Leach Eye Hosptial;Bascom Palmer Eye Institute Miami, Florida, United States
View all 13 locations
View Trial Details
Completed

Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis

NCT02746991

Conditions
Eye Diseases, Intermediate Uveitis, Panuveitis, +5 more
Locations
  • LV. Prasad Eye Institute Hyderabad, Andhra Pradesh, India
  • Sri Sankaradeva Nethralaya, Guwahati Guwahati, Assam, India
  • Regional Institute of Opthalmology Patna, Bihar, India
  • C.H. Nagri Municipal Eye Hospital Ahmedabad, Gujarat, India
View all 15 locations
View Trial Details
Completed

Safety and Efficacy of AIN457 in Noninfectious Uveitis

NCT00685399

Conditions
Autoimmune Diseases, Behcet Syndrome, Birdshot Chorioretinopathy, +36 more
Locations
  • Novartis Investigative Site Beverly Hills, California, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Sacramento, California, United States
  • Novartis Investigative Site Denver, Colorado, United States
View all 23 locations
View Trial Details
Completed

Phase III Study in Refractory Behcet's Disease

NCT00995709

Conditions
Behcet Disease, Behcet Syndrome, Cardiovascular Diseases, +18 more
Locations
  • Novartis Investigative Site Baltimore, Maryland, United States
  • Novartis Investigative Site Arlington, Texas, United States
  • Novartis Investigative Site Houston, Texas, United States
  • Novartis Investigative Site Alexandria, Egypt
View all 49 locations
View Trial Details
Completed

A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis

NCT00404612

Conditions
Eye Diseases, Panuveitis, Uveal Diseases, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Retinal Consultants of Arizona Phoenix, Arizona, United States
  • University of Illinois - Chicago Chicago, Illinois, United States
  • Midwest Eye Institute Indianapolis, Indiana, United States
View all 41 locations
View Trial Details
Completed

A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis

NCT00404742

Conditions
Eye Diseases, Panuveitis, Uveal Diseases, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Retinal Consultants of Arizona Phoenix, Arizona, United States
  • University of Illinois - Chicago Chicago, Illinois, United States
  • Midwest Eye Institute Indianapolis, Indiana, United States
View all 41 locations
View Trial Details
Completed

A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis

NCT00404885

Conditions
Eye Diseases, Inflammation, Panuveitis, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Retinal Consultants of Arizona Phoenix, Arizona, United States
  • University of Illinois - Chicago Chicago, Illinois, United States
  • Wilmer Eye Institute Baltimore, Maryland, United States
View all 30 locations
View Trial Details

Related conditions